Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
J Perinatol ; 37(11): 1224-1229, 2017 11.
Article in English | MEDLINE | ID: mdl-28749479

ABSTRACT

OBJECTIVE: Delivering prognostic information to families requires clinicians to forecast an infant's illness course and future. We lack robust empirical data about how prognosis is shared and how that affects clinician-family concordance regarding infant outcomes. STUDY DESIGN: Prospective audiorecording of neonatal intensive care unit family conferences, immediately followed by parent/clinician surveys. Existing qualitative analysis frameworks were applied. RESULTS: We analyzed 19 conferences. Most prognostic discussion targeted predicted infant functional needs, for example, medications or feeding. There was little discussion of how infant prognosis would affect infant/family quality of life. Prognostic framing was typically optimistic. Most parents left the conference believing their infant's prognosis to be more optimistic than did clinicians. CONCLUSIONS: Clinician approach to prognostic disclosure in these audiotaped family conferences tended to be broad and optimistic, without detail regarding implications of infant health for infant/family quality of life. Families and clinicians left these conversations with little consensus about infant prognosis.


Subject(s)
Parents/psychology , Professional-Family Relations , Prognosis , Truth Disclosure , Communication , Counseling/standards , Critical Illness/psychology , Critical Illness/therapy , Female , Humans , Infant , Infant, Newborn , Intensive Care Units, Neonatal , Male , Perception , Qualitative Research , Quality of Life , Video Recording
2.
J Neonatal Perinatal Med ; 8(3): 199-205, 2015.
Article in English | MEDLINE | ID: mdl-26485552

ABSTRACT

OBJECTIVE: To evaluate the nutritional impact of a feed-holding guideline during transfusion for infants <32 weeks gestation. STUDY DESIGN: A pre-/post-interventional study was conducted after introduction of a guideline to hold feeds during transfusion. Demographic variables in addition to nutritional outcomes were collected on all infants admitted within 48 hours of birth with gestational age <32 weeks. Data was collected during a 6 month period pre-intervention and the 6 month period post-intervention. RESULTS: There were 145 eligible infants. Mean birth weight and gestational age were similar in both periods. In total, 98 infants received transfusions, and 82 of those had an active feeding order prior to at least one transfusion. Total transfusions per infant and transfusions ordered while an infant had active feeding orders were similar in both periods. Time to full feedings was decreased post-intervention (p <  0.001). Weight at 34 weeks, incidence of second IV placement, additional IV fluid use, and hypoglycemia were similar between groups.Of 593 total transfusions, 207 were ordered while an infant had an active order for enteral nutrition. Pre-intervention, 64% of transfusions had feeds held during transfusion. Post-intervention, 87% of transfusions had feeds held during transfusion. Feeds were held more often (p <  0.001) and for a shorter duration (p = 0.005) in the post-intervention group. CONCLUSION: Implementing a guideline standardizing feeding practices during transfusions in premature infants increases standardization of care and results in decreased variability in practice. Adverse nutritional consequences were not found after the introduction of the routine practice of holding feedings during transfusion in preterm infants.


Subject(s)
Enteral Nutrition/methods , Erythrocyte Transfusion , Infant, Very Low Birth Weight , Intensive Care, Neonatal/methods , Withholding Treatment/statistics & numerical data , Follow-Up Studies , Humans , Infant, Newborn , Infant, Premature
3.
J Neonatal Perinatal Med ; 6(1): 37-44, 2013.
Article in English | MEDLINE | ID: mdl-24246457

ABSTRACT

OBJECTIVE: To determine if changes have occurred in the causative pathogens and/or antibiotic susceptibility profiles in early onset neonatal infections since initiation of group B Streptococcus (GBS) prophylaxis and to determine risk factors for ampicillin/penicillin resistant microorganisms. STUDY DESIGN: Data on 220 infants with positive blood, urine, or cerebrospinal fluid cultures for bacteria or fungi at ≤seven days of age from 1990-2007 were examined and divided into three epochs, based on intrapartum antibiotic prophylactic (IAP) practices. Pathogens and antibiotic resistance were compared among epochs. RESULTS: A significant decrease in the incidence of GBS infections occurred over time, with no change in the incidence of other pathogens or the emergence of antibiotic resistance, including the very low-birthweight population. In regression analysis, ampicillin resistance was associated with male gender (OR 3.096). CONCLUSIONS: No emergence of antibiotic resistant pathogens was found following IAP use. Changing microorganisms and increasing antibiotic resistance found in prior studies are likely multifactorial. Further study is needed to continue to reduce the rates of common early onset pathogens.


Subject(s)
Antibiotic Prophylaxis , Drug Resistance, Microbial , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy Complications, Infectious/prevention & control , Streptococcal Infections/prevention & control , Streptococcus agalactiae/pathogenicity , Adult , Female , Humans , Infant, Newborn , Male , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/microbiology , Prenatal Care/methods , Risk Factors , Sentinel Surveillance , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology
4.
J Perinatol ; 33(3): 206-11, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22699358

ABSTRACT

OBJECTIVE: To determine trends in late-onset neonatal infections and risk factors for ampicillin/penicillin-resistant microorganisms. STUDY DESIGN: Data on 584 infants with positive blood, urine or cerebrospinal fluid cultures for bacteria or fungi at 8-30 days of age from 1990 to 2007 were examined and divided into three epochs, based on intrapartum antibiotic prophylactic (IAP) practices. Pathogens and antibiotic resistance were compared among epochs. RESULT: The number of candidal infections increased over time for the entire population (P=0.006). There was an increased incidence of Gram-negative (P=0.009) and candidal infections (P=0.014) among very low-birthweight infants. Only Escherichia coli infections showed increasing ampicillin resistance over epochs (P=0.006). In regression analysis, ampicillin/penicillin resistance increased with IAP use (odds ratio 2.05). CONCLUSION: Changing microorganisms and increasing antibiotic resistance in late-onset neonatal infections are likely multifactorial but are increased with IAP use, which may identify an at-risk population. Increasing Candida infections require further investigation.


Subject(s)
Ampicillin Resistance , Antibiotic Prophylaxis , Streptococcal Infections/epidemiology , Streptococcal Infections/prevention & control , Streptococcus agalactiae , Adult , Age of Onset , Cross Infection/epidemiology , Cross Infection/prevention & control , Escherichia coli Infections/prevention & control , Female , Humans , Infant, Newborn , Risk Factors
5.
J Perinatol ; 33(4): 278-81, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22899183

ABSTRACT

OBJECTIVE: To compare mothers' and clinicians' understanding of an infant's illness and perceptions of discussion quality in the neonatal intensive care unit. STUDY DESIGN: English-speaking mothers with an infant admitted to the intensive care unit for at least 48 h were interviewed using a semi-structured survey. The clinician whom the mother had spoken to and identified was also surveyed. Interviews were audiotaped and transcribed. RESULT: A total of 101 mother-clinician pairs were interviewed. Most mothers (89%) and clinicians (92%) felt that their discussions had gone well. Almost all mothers could identify one of their infant's diagnoses (100%) and treatments (93.4%). Mothers and clinicians disagreed on infant illness severity 45% of the time. The majority of mothers (62.5%) who disagreed with clinician estimate of infant illness severity believed their infant to be less sick than indicated by the clinician. CONCLUSION: Mother-clinician satisfaction with communication does not ensure mother-clinician agreement about an infant's medical status.


Subject(s)
Attitude of Health Personnel , Consumer Behavior , Intensive Care, Neonatal , Mothers/psychology , Patient Acuity , Attitude to Health , Critical Illness/psychology , Critical Illness/therapy , Dissent and Disputes , Female , Health Literacy , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Intensive Care, Neonatal/methods , Intensive Care, Neonatal/psychology , Qualitative Research , Severity of Illness Index , Social Perception , Workforce
6.
J Perinatol ; 32(12): 901-6, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22743406

ABSTRACT

When discussing the benefits and burdens of medical interventions for critically ill infants, clinicians and families are challenged to weigh the uncertainties of treatment success with infant pain and suffering. Concrete measures of infant suffering or quality of life, which could inform infant care and decision-making are lacking. Although consistent and reliable health-related quality of life (HRQOL) definitions and measures have been extensively developed for adults and older children, they have not been relevant to neonates or infants. Advancing HRQOL research methodology is an objective of Healthy People 2020. This paper will review the evidence and practices relevant to HRQOL with a focus on intensive care and pediatric settings. We will highlight existing HRQOL measures, which could be adapted for neonates and existing neonatal intensive care unit measures and practices, which could inform new measures of HRQOL.


Subject(s)
Infant Care/standards , Infant Welfare , Intensive Care Units, Neonatal , Patient Care Team/organization & administration , Quality of Life , Critical Care/methods , Critical Illness/therapy , Decision Making , Female , Humans , Infant , Infant, Newborn , Male , Outcome Assessment, Health Care , Pain Measurement , Treatment Outcome , United States
7.
J Perinatol ; 32(9): 685-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22094490

ABSTRACT

OBJECTIVE: Following patent ductus arteriosus (PDA) ligation, preterm infants may develop profound hypotension and respiratory failure. Prophylactic stress hydrocortisone (HC) has emerged as a therapy to prevent complications, postulating these infants do not synthesize steroids because of an immature hypothalamic-pituitary-adrenal axis. The purpose of this study was to compare outcomes in infants who received stress HC before their PDA ligations to those who did not. STUDY DESIGN: A retrospective chart review was performed of infants who underwent PDA ligations at our institution's neonatal intensive care unit. Data were collected on treatment with HC, and respiratory and cardiovascular support. RESULT: Gestational age (GA) and birth weight were lower in the HC group (24 vs 25 weeks, 632 vs 790 g), but age at time of surgery was similar (26 vs 21 days). Cardiorespiratory support was comparable between the groups pre- and post-operatively. In regression models that adjusted for GA, HC treatment was not independently related to respiratory support postoperatively, but was associated with a decrease in postoperative dopamine (2.2 mcg kg(-1) min(-1); P=0.03). Respiratory support postoperatively was predicted by preoperative respiratory support. GA and age at surgery were not independently associated with outcome. CONCLUSION: Preoperative stress HC was not associated with improved cardiorespiratory stability, regardless of GA. Further investigation is needed to identify infants who may benefit from this therapy.


Subject(s)
Ductus Arteriosus, Patent/surgery , Hydrocortisone/administration & dosage , Hypotension/prevention & control , Infant, Premature, Diseases/surgery , Postoperative Complications/prevention & control , Respiratory Insufficiency/prevention & control , Cardiotonic Agents/therapeutic use , Dopamine/therapeutic use , Epinephrine/therapeutic use , Humans , Hypotension/etiology , Hypotension/therapy , Infant, Newborn , Infant, Premature , Ligation , Postoperative Complications/therapy , Preoperative Care , Respiratory Insufficiency/etiology , Respiratory Insufficiency/therapy
8.
J Perinatol ; 30(7): 484-8, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20010616

ABSTRACT

OBJECTIVE: Both excess and insufficient levels of glucocorticoid in extremely low birth weight (ELBW) infants have been associated with adverse hospital outcomes, whereas excess glucocorticoid exposure has been associated with long-term adverse neurodevelopment. Our objective was to evaluate the relationship between neonatal cortisol concentrations and long-term outcomes of growth and neurodevelopment. STUDY DESIGN: As part of a multicenter randomized trial of hydrocortisone treatment for prophylaxis of relative adrenal insufficiency, cortisol concentrations were obtained at 12 to 48 h of postnatal age and at days 5 to 7 on 350 intubated ELBW infants, of whom 252 survived and returned for neurodevelopmental follow-up at 18 to 22 months corrected age. Cortisol values from each time point were divided into quartiles. Growth and neurodevelopmental outcome were compared for each quartile. RESULT: Median cortisol value was 16.0 microg per 100 ml at baseline for all infants, and 13.1 microg per 100 ml on days 5 to 7 in the placebo group. Outcomes did not differ in each quartile between treatment and placebo groups. Low cortisol values at baseline or at days 5 to 7 were not associated with impaired growth or neurodevelopment at 18 to 22 months corrected age. High cortisol values were associated with an increase in cerebral palsy, related to the increased incidence of severe intraventricular hemorrhage (IVH) and periventricular leukomalacia. CONCLUSION: Low cortisol concentrations were not predictive of adverse long-term outcomes. High cortisol concentrations, although predictive of short-term adverse outcomes such as IVH and periventricular leukomalacia, did not additionally predict adverse outcome. Further analysis into identifying factors that modulate cortisol concentrations shortly after birth could improve our ability to identify those infants who are most likely to benefit from treatment with hydrocortisone.


Subject(s)
Adrenal Insufficiency/blood , Hydrocortisone/blood , Infant, Extremely Low Birth Weight/blood , Adrenal Insufficiency/drug therapy , Anti-Inflammatory Agents/administration & dosage , Female , Humans , Hydrocortisone/administration & dosage , Infant, Newborn , Male , Risk Factors , Treatment Outcome
9.
J Perinatol ; 30(4): 286-90, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19812590

ABSTRACT

OBJECTIVE: We aimed to characterize adolescent parents' understanding of their infant's diagnosis, treatment and illness severity in the intensive care unit. STUDY DESIGN: Adolescent mothers were interviewed and neonatal medical records were reviewed. RESULT: Forty-two teens were interviewed. All had spoken with providers: 86% with nurses, 60% with physicians and 45% with both. Most teens could name their infant's diagnosis and treatment but often underestimated the illness severity. Teens reported reluctance to ask providers to clarify technical language. Those who said they spoke with a physician were less likely to understand their infant's illness severity than those who said they had not spoken with a physician (48 vs 82%). Parents' knowledge was better if physicians had documented explicit efforts to communicate with parents. CONCLUSION: Teens often underestimated the critical nature of their infant's illness. Future work should target adolescent willingness to ask questions and provider ability to accurately gauge parent knowledge.


Subject(s)
Health Knowledge, Attitudes, Practice , Intensive Care Units, Neonatal , Mothers , Adolescent , Educational Status , Female , Humans , Interviews as Topic , Nurse-Patient Relations , Physician-Patient Relations , Young Adult
10.
J Perinatol ; 29(8): 575-81, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19262570

ABSTRACT

OBJECTIVE: To characterize parents' perception of back-transport of very-low-birth-weight (VLBW) infants from a regional referral neonatal intensive care unit (RR-NICU) to a community hospital (CH) for convalescent care. STUDY DESIGN: Mixed methods utilizing parental interview and medical record review. RESULT: Overall, 20% of parents selected the CH to which their child was transferred. Less than half of the parents wanted the transfer. Psychological comfort with the RR-NICU was the most frequently reported reason for opposing transfer. At the time of home discharge, most parents were satisfied with the transfer and felt prepared to care for their infant at home. CONCLUSION: Parents want their infants closer to home, but are worried about the unknown. They are willing to forfeit autonomy in decision-making regarding the site of convalescent care. Parents need better preparation for transfer. Including them in an advisory group that reviews transfer policies could ameliorate the transition.


Subject(s)
Health Knowledge, Attitudes, Practice , Infant, Very Low Birth Weight , Parents , Patient Satisfaction , Referral and Consultation , Female , Hospitals, Community , Humans , Infant, Newborn , Intensive Care, Neonatal , Interviews as Topic , Male , Patient Transfer
11.
J Perinatol ; 28(2): 141-8, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18059466

ABSTRACT

OBJECTIVE: To determine the incidence and associated complications of atypical chronic lung disease (ACLD) in extremely low birth weight infants. STUDY DESIGN: All infants born at Johns Hopkins Hospital between 1996 and 2001, with birthweight <1000 g, gestational age <31 weeks, no major anomalies or genetic syndromes, and living at least 21 days were eligible for inclusion. Data pertaining to demographics, hospital course, diagnosis of atypical chronic lung disease, patterns of surfactant use, complications of prematurity and severity of lung disease were collected. RESULT: Using inclusion criteria, 215 eligible infants were identified, of which 185 had hospital charts available for review. Twenty-eight infants (15%) met the criteria for atypical chronic lung disease. Of the remaining 157 infants, 57 patients met the criteria for mild bronchopulmonary dysplasia (BPD) (supplemental oxygen requirement at 28 days of life), 38 patients had moderate/severe BPD (supplemental oxygen requirement at both 28 days of life and 36 weeks post-menstrual age), and 38 infants did not have chronic lung disease. Infants with ACLD had much higher rates of sepsis (46%) and pneumothorax (18%) than infants in the comparison groups. CONCLUSION: Infants with respiratory distress syndrome in the first week of life, which initially resolves are still at risk for an atypical form of chronic lung disease. The prolonged respiratory support they require as a result of this type of lung disease increases their risk for complications of prematurity, which may outlast their lung disease. We speculate that inflammation secondary to infection acquired shortly after birth may be an important step in the pathogenesis of ACLD.


Subject(s)
Infant, Extremely Low Birth Weight , Infant, Premature, Diseases/epidemiology , Lung Diseases/epidemiology , Bronchopulmonary Dysplasia/epidemiology , Chronic Disease , Female , Humans , Infant, Newborn , Infant, Premature , Length of Stay , Male , Oxygen/administration & dosage , Pneumothorax/epidemiology , Pulmonary Surfactants/administration & dosage , Respiration, Artificial/adverse effects , Respiratory Distress Syndrome, Newborn/epidemiology , Retrospective Studies
12.
J Perinatol ; 27(5): 259-61, 2007 May.
Article in English | MEDLINE | ID: mdl-17453038

ABSTRACT

The diagnosis of cerebral palsy is based on evidence of impairment of the motor system, but symptoms become evident only as a premature infant matures. The diagnosis is made typically at 18 to 24 months of age, corrected for gestational age at birth. An earlier and more accurate way to identify infants destined to develop cerebral palsy may help improve the prognosis for this vulnerable population. For now, no antenatal, perinatal or postnatal test can predict cerebral palsy with a degree of certainty high enough to help providers or parents plan for an infant's future or make the best use of early intervention resources.


Subject(s)
Cerebral Palsy/diagnosis , Infant, Premature, Diseases/diagnosis , Early Diagnosis , Humans , Infant , Infant, Newborn , Infant, Very Low Birth Weight , Magnetic Resonance Imaging , Prognosis
13.
Pediatr Cardiol ; 23(4): 403-9, 2002.
Article in English | MEDLINE | ID: mdl-12170356

ABSTRACT

The aim of this study was to assess the utility of arm and leg oxygen saturation as a candidate screening test for the early detection of ductal-dependent left heart obstructive disease. We measured arm and leg oxygen saturation in 2876 newborns admitted to well baby nurseries and 32 newborns with congenital heart disease. Fifty-seven newborns in the well baby nurseries (0.02%) had an abnormal test (leg saturation less than 92% in room air or 7% lower saturation in the leg than in the arm). Four of the 57 had critical congenital heart disease, including 1 with coarctation of the aorta. Of the 32 newborns with congenital heart disease, 11/13 (85%) with left heart obstructive disease had abnormal oxygen saturation tests, as did 15/19 (79%) with other forms of congenital heart disease. Pulse oximetry deserves further study as a screening test for critical congenital heart disease.


Subject(s)
Heart Defects, Congenital/diagnosis , Oxygen/blood , Baltimore/epidemiology , Birth Weight/physiology , Case-Control Studies , Cohort Studies , Echocardiography , Extremities/blood supply , Female , Follow-Up Studies , Gestational Age , Heart Defects, Congenital/physiopathology , Heart Rate/physiology , Humans , Infant Welfare , Infant, Newborn , Male , Oximetry , Prevalence , Sensitivity and Specificity , Suburban Health , Urban Health
15.
J Perinatol ; 19(6 Pt 1): 426-31, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10685272

ABSTRACT

OBJECTIVE: To describe current skin care practices for preterm infants in neonatal intensive care units in the United States. We hypothesized that there would be little consensus among facilities. STUDY DESIGN: Neonatal intensive care units (n = 823) listed in the 1996 United States Neonatologists Directory (American Academy of Pediatrics, Section on Perinatal Pediatrics) were sent a 28-question survey dealing with many aspects of neonatal skin care along with descriptive data about their neonatal intensive care unit. Descriptive data analysis was performed. RESULTS: A total of 305 surveys were returned (37% return rate); of these, 241 of the respondents reported admitting infants weighing < or = 1000 gm. Some neonatal skin care practices showed wide consensus (> 70%) (e.g., scrub procedure for staff; use of a skin barrier under tapes/adhesives), whereas other practices showed little consensus (< 30%) (e.g., routine surveillance cultures; use of Aquaphor). CONCLUSION: Consensus on skin care practices was not found among neonatal intensive care units. Data from this survey can be used to develop studies to examine whether certain skin care management practices can improve neonatal outcomes.


Subject(s)
Infant, Premature , Intensive Care Units, Neonatal , Skin Care , Body Temperature Regulation , Data Collection , Humans , Hygiene , Infant, Newborn , Skin/injuries , United States , Water Loss, Insensible , Wounds and Injuries/prevention & control , Wounds and Injuries/therapy
17.
J Perinatol ; 18(5): 347-51, 1998.
Article in English | MEDLINE | ID: mdl-9766409

ABSTRACT

OBJECTIVE: To understand how neonatologists' perceptions of viability impact their willingness to recommend or provide medical interventions for infants born at 23 to 24 weeks' gestation. STUDY DESIGN: A 25-question survey mailed to 3056 neonatologists in the United States in 1992 yielded 1131 responses. Seven hundred seventy-five (775 of 1131, 69%) reported they believed that the lower limit of viability was 23 to 24 weeks' gestation. These respondents were asked if they were willing to recommend or provide a series of medical interventions for infants born at 23 and 24 weeks' gestation. RESULTS: Most respondents would provide ventilation (82% and 95%) and surfactant (62% and 78%) for infants born at 23 and 24 weeks' gestation, respectively. The respondent's prediction of <100% mortality, infant factors, and parental wishes were significant predictors of willingness to resuscitate infants born at 23 weeks' gestation. CONCLUSION: There is considerable variation among neonatologists in their willingness to recommend or provide medical interventions for infants born at 23 to 24 weeks' gestation.


Subject(s)
Attitude of Health Personnel , Health Care Rationing/statistics & numerical data , Infant, Premature , Infant, Very Low Birth Weight , Intensive Care Units, Neonatal/statistics & numerical data , Intensive Care, Neonatal/statistics & numerical data , Gestational Age , Health Care Surveys/statistics & numerical data , Humans , Infant Mortality , Infant, Newborn , Perception , Practice Patterns, Physicians'/statistics & numerical data , United States
18.
Pediatrics ; 100(1): 39-50, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9200358

ABSTRACT

OBJECTIVE: To compare the efficacy and safety of a synthetic surfactant (Exosurf Neonatal, Burroughs Wellcome Co) and a surfactant extract of calf lung lavage (Infasurf, IND #27,169, ONY, Inc) in the prevention of neonatal respiratory distress syndrome (RDS). DESIGN AND SETTING: Ten-center randomized masked comparison trial. PATIENTS: Premature infants (n = 871) <29 weeks gestational age by best obstetric estimate. INTERVENTIONS: Infants were randomly assigned to a course of treatment with Exosurf Neonatal (n = 438) or Infasurf (n = 433) at birth, and if still intubated, at 12 and 24 hours of age. Crossover treatment was allowed within 72 hours of age if severe respiratory failure (defined as two consecutive a/A PO2 ratios

Subject(s)
Fatty Alcohols/therapeutic use , Phosphorylcholine , Polyethylene Glycols/therapeutic use , Pulmonary Surfactants/therapeutic use , Respiratory Distress Syndrome, Newborn/prevention & control , Age Factors , Bronchopulmonary Dysplasia/prevention & control , Cerebral Hemorrhage/prevention & control , Data Interpretation, Statistical , Drug Combinations , Fatty Alcohols/administration & dosage , Fatty Alcohols/adverse effects , Female , Humans , Infant, Newborn , Linear Models , Male , Polyethylene Glycols/administration & dosage , Polyethylene Glycols/adverse effects , Pulmonary Surfactants/administration & dosage , Pulmonary Surfactants/adverse effects , Respiratory Distress Syndrome, Newborn/mortality , Time Factors , Treatment Outcome
19.
Pediatrics ; 97(4): 481-5, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8632932

ABSTRACT

OBJECTIVE: This study measures the incidence of discrepancies among written prescriptions, medication regimens transcribed onto patient discharge instruction sheets (DCIs), and labels on medications dispensed by community pharmacies after discharge of patients from an academic medical center. METHODS: During a 2-month study period, we collected copies of prescriptions and DCIs. We also called care givers after discharge and asked them to read the medication labels that were filled from discharge prescriptions. Care givers were also asked whether they received instruction from community pharmacies. RESULTS: Data were collected on 335 prescriptions for 192 patients. Differences among the prescriptions, DCIs, and medication labels were found for 40 (12%) of the medications prescribed at discharge, representing 19% of the patients studied. Nineteen prescriptions had prescriber errors in dosing frequencies or dosage formulations. Three prescriptions were filled with different medication concentrations or strengths than requested. Prescriptions were altered by the community pharmacists for unexplained reasons in 6 cases, whereas the DCIs and original prescriptions differed in 12 cases. Only 44% of families were counseled about proper medication administration by their pharmacists. CONCLUSIONS: A potential for medication errors exists when pediatric patients are discharged with unfilled prescriptions. The potential may be worsened when discharge instructions are created from a prescription rather than from the label of a dispensed medication. Educational and risk-management efforts should emphasize the importance of writing complete, legible prescriptions and consulting appropriate reference materials to ensure that dose formulations and guidelines are accurate. Whenever possible, prescriptions should be filled before patients are discharged, so that the dispensed medications can be reviewed, and health care providers can provide accurate discharge instructions.


Subject(s)
Patient Discharge , Pharmaceutical Preparations , Academic Medical Centers , Adolescent , Baltimore , Caregivers , Chemistry, Pharmaceutical , Child , Child, Preschool , Counseling , Drug Compounding , Drug Labeling , Guidelines as Topic , Hospitals, Teaching , Humans , Infant , Medication Errors , Patient Education as Topic , Pharmaceutical Preparations/administration & dosage , Pharmacies , Pharmacists , Professional-Family Relations , Risk Management , Writing
20.
J Pediatr ; 128(3): 396-406, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8774514

ABSTRACT

OBJECTIVE: To compare the efficacy and safety of two surfactant preparations in the treatment of respiratory distress syndrome (RDS). METHODS: We conducted a randomized, masked comparison trial at 21 centers. Infants with RDS who were undergoing mechanical ventilation were eligible for treatment with two doses of either a synthetic (Exosurf) or natural (Infasurf) surfactant if the ratio of arterial to alveolar partial pressure of oxygen was less than or equal to 0.22. Crossover treatment was allowed within 96 hours of age if severe respiratory failure (defined as two consecutive arterial/alveolar oxygen tension ratios < or = 0.10) persisted after two doses of the randomly assigned surfactant. Four primary outcome measures of efficacy (the incidence of pulmonary air leak (< or = 7 days); the severity of RDS; the incidence of death from RDS; and the incidence of survival without bronchopulmonary dysplasia (BPD) at 28 days after birth) were compared by means of linear regression techniques. RESULTS: The primary analysis of efficacy was performed in 1033 eligible infants and an analysis of safety outcomes in the 1126 infants who received study surfactant. Preentry demographic characteristics and respiratory status were similar for the two treatment groups, except for a small but significant difference in mean gestational age (0.5 week) that favored the infasurf treatment group. Pulmonary air leak (< or = 7 days) occurred in 21% of Exosurf- and 11% of infasurf-treated infants (adjusted relative risk, 0.53; 95% confidence interval, 0.40 to 0.71; p < or = 0.0001). During the 72 hours after the initial surfactant treatment, the average fraction of inspired oxygen (+/-SEM) was 0.47 +/- 0.01 for Exosurf- and 0.39 +/- 0.01 for infasurf-treated infants (difference, 0.08; 95% confidence interval, 0.06 to 0.10; p < 0.0001); the average mean airway pressure (+/-SEM) was 8.6 +/- 0.1 cm H2O; for Exosurf- and 7.2 +/- 0.1 cm H2O for Infasurf-treated infants (difference, 1.4 cm H2O; 95% confidence interval, 1.0 to 1.8 cm H2O; p < 0.0001). The incidences of RDS-related death, total respiratory death, death to discharge, and survival without bronchopulmonary dysplasia at 28 days after birth did not differ. The number of days of more than 30% inspired oxygen and of assisted ventilation, but not the duration of hospitalization, were significantly lower in Infasurf-treated infants. CONCLUSION: Compared with Exosurf, Infasurf provided more effective therapy for RDS as assessed by significant reductions in the severity of respiratory disease and in the incidence of air leak complications.


Subject(s)
Phosphorylcholine , Pulmonary Surfactants/therapeutic use , Respiratory Distress Syndrome, Newborn/therapy , Bronchopulmonary Dysplasia/epidemiology , Cross-Over Studies , Drug Combinations , Fatty Alcohols/therapeutic use , Humans , Incidence , Infant, Newborn , Length of Stay , Linear Models , Pneumothorax/epidemiology , Polyethylene Glycols/therapeutic use , Pulmonary Emphysema/epidemiology , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/mortality , Survival Rate , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL